CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma-Reference-Cited by-同舟云学术

CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma

Published:2020-03-06 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Sussman Robyn T.,Rokita Jo Lynne,Huang Kevin,Raman Pichai,Rathi Komal S.,Martinez Daniel,Bosse Kristopher R.,Lane Maria,Hart Lori S.,Bhatti Tricia,Pawel Bruce,Maris John M.

Funder

American Association for Cancer Research

Alex's Lemonade Stand Foundation for Childhood Cancer

National Institutes of Health

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference52 articles.

1. Recent advances in neuroblastoma;Maris;N Engl J Med.,2010

2. Neuroblastoma;Matthay;Nat Rev Dis Primers.,2016

3. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma;Yu;N Engl J Med.,2010

4. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour;Schwab;Nature.,1983

5. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage;Brodeur;Science.,1984

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paraneoplastic Calmodulin Kinase‐Like Vesicle‐Associated Protein (CAMKV) Autoimmune Encephalitis;Annals of Neurology;2024-04-18

2. Vitamin D, Calbindin, and calcium signaling: Unraveling the Alzheimer's connection;Cellular Signalling;2024-04

3. CAMKV Kinase Signaling Is a Novel Therapeutic Avenue with Prognostic Relevance in Neuroblastoma;2024-02-22

4. A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in Neuroblastoma;Biomedicines;2024-01-16

5. A novel druggable DYRK3/CAMKV signaling module for Neuroblastoma tumor growth inhibition;2023-12-01